Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.

Saved in:
Bibliographic Details
Title: Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease.
Authors: Pisanò CA; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44122, Ferrara, Italy., Brugnoli A; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44122, Ferrara, Italy., Novello S; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44122, Ferrara, Italy., Caccia C; Open R&D Department, Zambon S.p.A, 20091, Bresso, MI, Italy., Keywood C; Open R&D Department, Zambon S.p.A, 20091, Bresso, MI, Italy., Melloni E; Open R&D Department, Zambon S.p.A, 20091, Bresso, MI, Italy., Vailati S; Open R&D Department, Zambon S.p.A, 20091, Bresso, MI, Italy., Padoani G; Open R&D Department, Zambon S.p.A, 20091, Bresso, MI, Italy., Morari M; Department of Medical Sciences, Section of Pharmacology, University of Ferrara, 44122, Ferrara, Italy. Electronic address: m.morari@unife.it.
Source: Neuropharmacology [Neuropharmacology] 2020 May 01; Vol. 167, pp. 108006. Date of Electronic Publication: 2020 Feb 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7064
DOI:10.1016/j.neuropharm.2020.108006